Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis

基于纳米颗粒的宿主定向疗法根除结核分枝杆菌

基本信息

  • 批准号:
    10613424
  • 负责人:
  • 金额:
    $ 31.82万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-04-06 至 2025-03-31
  • 项目状态:
    未结题

项目摘要

SUMMARY Tuberculosis remains a major global public health threat. Although relatively effective drug regimens are available, treatment failure remains a major roadblock to tuberculosis control. This is in part due to a high incidence of drug-resistant Mycobacterium tuberculosis (Mtb) strains, as well as the phenomenon of bacterial persistence. Persisters represent a reservoir of latent infection, which may progress to active disease when host immunity is compromised (e.g., with HIV co-infection), and also potentially contribute to the emergence of further drug resistance. Mtb is able to subvert key innate immune defence mechanisms exerted by the host macrophage; it can dampen the immune response, subvert macrophage killing and create a protected niche within this host cell. In the proposed work, the capacity of engineered nanoparticles to favourably modulate the response of macrophage, through delivered immunomodulatory signals, and achieve death of intracellular Mtb, will be investigated. These unique nanoparticles mimic Mtb (i.e. bacteriomimetic) in selected aspects of size, shape and composition. The nanoparticles proposed here are lipid polymer hybrid nanoparticles and metal organic frameworks (spherical and rod shaped) incorporating mycolic acids and/or the fungal wall polysaccharide β- glucan. Strong published and preliminary data demonstrates the capacity of the polymer nanoparticles to induce killing of virulent Mtb in macrophages. This killing is only evident in intracellular Mtb and is similar to that achieved using an antibiotic. Metal organic framework nanoparticles can be synthesized and coated with macrophage targeting materials. The hypothesis of the project is that bacteriomimetic, immunotherapeutic nanoparticles will be effective against all forms of Mtb (including drug-resistant and persister populations) through immune modulation. Specifically, the project has 3 aims: 1) Characterize a panel of bacteriomimetic immunotherapeutic NPs; 2) Investigate response of infected macrophages and intracellular bacteria to the panel of NPs; 3) Assess in vivo response to, and efficacy of, NPs in murine infection model. This project is at the cutting edge of nanotechnology and tuberculosis research, and will provide several exciting research capacity development opportunities for scientists from South Africa and Zimbabwe (through a partnership with an on-going NIH funded HIV Research Training Program). The multi-national research team will be led by 3 new investigators, with research teams from Stellenbosch University, South Africa, the University of the Western Cape (a historically disadvantaged institution in South Africa) and South Dakota State University in the USA, partnered to propose a novel immunotherapy approach for tuberculosis based on nanoparticle-based delivery systems. The team has expertise in nanoparticle formulation and characterisation, in vitro and in vivo infection models, and tuberculosis immunology. Our results will advance the development of nanoparticle-based, host-directed therapies for tuberculosis.
概括 结核病仍然是全球主要的公共卫生威胁。虽然相对有效的药物治疗方案 尽管治疗失败仍然是控制结核病的主要障碍。这部分是由于高 耐药结核杆菌(Mtb)菌株的发生率以及细菌现象 坚持。持续存在者代表潜伏感染的储存库,当宿主感染时,可能会发展为活动性疾病。 免疫力受到损害(例如,艾滋病毒合并感染),也可能导致进一步出现 耐药性。 Mtb 能够破坏宿主巨噬细胞发挥的关键先天免疫防御机制; 它可以抑制免疫反应,破坏巨噬细胞的杀伤作用,并在宿主体内创造一个受保护的生态位 细胞。在拟议的工作中,工程纳米粒子有利地调节响应的能力 巨噬细胞通过传递免疫调节信号,实现细胞内Mtb的死亡, 调查了。这些独特的纳米粒子在尺寸、形状和形状等选定方面模仿 Mtb(即拟菌)。 作品。这里提出的纳米颗粒是脂质聚合物杂化纳米颗粒和金属有机纳米颗粒 结合分枝菌酸和/或真菌壁多糖β-的框架(球形和杆形) 葡聚糖。已发表的强有力的初步数据证明了聚合物纳米粒子诱导 杀死巨噬细胞中的剧毒结核分枝杆菌。这种杀灭仅在细胞内 Mtb 中明显,并且与所实现的杀灭类似 使用抗生素。可以合成金属有机框架纳米粒子并用巨噬细胞包被 靶向材料。该项目的假设是,拟菌免疫治疗纳米颗粒将 通过免疫有效对抗所有形式的 Mtb(包括耐药性和持续性人群) 调制。具体来说,该项目有 3 个目标:1) 表征一组拟菌免疫治疗药物 纳米颗粒; 2) 研究受感染的巨噬细胞和细胞内细菌对纳米粒子组的反应; 3)评估 小鼠感染模型中纳米颗粒的体内反应和功效。该项目处于最前沿 纳米技术和结核病研究,并将提供几项令人兴奋的研究能力发展 为来自南非和津巴布韦的科学家提供机会(通过与正在进行的 NIH 资助的项目合作) 艾滋病毒研究培训计划)。这个多国研究小组将由 3 名新研究人员领导,其中 来自南非斯泰伦博斯大学、西开普大学(历史上的一所)的研究团队 南非的弱势机构)和美国南达科他州立大学合作提出了一项 基于纳米颗粒递送系统的新型结核病免疫治疗方法。团队有 纳米颗粒配方和表征、体外和体内感染模型以及结核病方面的专业知识 免疫学。我们的研究结果将推动基于纳米颗粒的宿主导向疗法的开发 结核。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Admire Dube其他文献

Admire Dube的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Admire Dube', 18)}}的其他基金

Nanoparticle-based host-directed therapies for eradication of Mycobacterium tuberculosis
基于纳米颗粒的宿主定向疗法根除结核分枝杆菌
  • 批准号:
    10376853
  • 财政年份:
    2020
  • 资助金额:
    $ 31.82万
  • 项目类别:
Development of Nanomedicines for Tuberculosis Treatment
结核病治疗纳米药物的开发
  • 批准号:
    9892050
  • 财政年份:
    2017
  • 资助金额:
    $ 31.82万
  • 项目类别:
Development of Nanomedicines for Tuberculosis Treatment
结核病治疗纳米药物的开发
  • 批准号:
    9401746
  • 财政年份:
    2017
  • 资助金额:
    $ 31.82万
  • 项目类别:

相似海外基金

An innovative, AI-driven prehabilitation platform that increases adherence, enhances post-treatment outcomes by at least 50%, and provides cost savings of 95%.
%20创新、%20AI驱动%20康复%20平台%20%20增加%20依从性、%20增强%20治疗后%20结果%20by%20at%20至少%2050%、%20和%20提供%20成本%20节省%20of%2095%
  • 批准号:
    10057526
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
    Grant for R&D
Improving Repositioning Adherence in Home Care: Supporting Pressure Injury Care and Prevention
提高家庭护理中的重新定位依从性:支持压力损伤护理和预防
  • 批准号:
    490105
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
    Operating Grants
I-Corps: Medication Adherence System
I-Corps:药物依从性系统
  • 批准号:
    2325465
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
    Standard Grant
Unintrusive Pediatric Logging Orthotic Adherence Device: UPLOAD
非侵入式儿科记录矫形器粘附装置:上传
  • 批准号:
    10821172
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
Nuestro Sueno: Cultural Adaptation of a Couples Intervention to Improve PAP Adherence and Sleep Health Among Latino Couples with Implications for Alzheimer’s Disease Risk
Nuestro Sueno:夫妻干预措施的文化适应,以改善拉丁裔夫妇的 PAP 依从性和睡眠健康,对阿尔茨海默病风险产生影响
  • 批准号:
    10766947
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
CO-LEADER: Intervention to Improve Patient-Provider Communication and Medication Adherence among Patients with Systemic Lupus Erythematosus
共同领导者:改善系统性红斑狼疮患者的医患沟通和药物依从性的干预措施
  • 批准号:
    10772887
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
  • 批准号:
    10594350
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
Antiretroviral therapy adherence and exploratory proteomics in virally suppressed people with HIV and stroke
病毒抑制的艾滋病毒和中风患者的抗逆转录病毒治疗依从性和探索性蛋白质组学
  • 批准号:
    10748465
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
Improving medication adherence and disease control for patients with multimorbidity: the role of price transparency tools
提高多病患者的药物依从性和疾病控制:价格透明度工具的作用
  • 批准号:
    10591441
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
Development and implementation of peer-facilitated decision-making and referral support to increase uptake and adherence to HIV pre-exposure prophylaxis in African Caribbean and Black communities in Ontario
制定和实施同行协助决策和转介支持,以提高非洲加勒比地区和安大略省黑人社区对艾滋病毒暴露前预防的接受和依从性
  • 批准号:
    491109
  • 财政年份:
    2023
  • 资助金额:
    $ 31.82万
  • 项目类别:
    Fellowship Programs
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了